Cleared Abbreviated

K110137 - ABX PENTRA ENZYMATIC CREATININE CP, ABX PENTRA MULTICAL, ABX PENTRA N CONTROL, ABX PENTRA P CONTROL, AND ABX PENTRA URIN (FDA 510(k) Clearance)

Aug 2011
Decision
204d
Days
Class 2
Risk

K110137 is an FDA 510(k) clearance for the ABX PENTRA ENZYMATIC CREATININE CP, ABX PENTRA MULTICAL, ABX PENTRA N CONTROL, ABX PENTRA P CONTROL, AND ABX PENTRA URIN. This device is classified as a Enzymatic Method, Creatinine (Class II - Special Controls, product code JFY).

Submitted by HORIBA ABX SAS (Montpellier, FR). The FDA issued a Cleared decision on August 10, 2011, 204 days after receiving the submission on January 18, 2011.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1225.

Submission Details

510(k) Number K110137 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 18, 2011
Decision Date August 10, 2011
Days to Decision 204 days
Submission Type Abbreviated
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code JFY - Enzymatic Method, Creatinine
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1225